In this situation, MCL-1 may play an essential role in sequestering partially active BAK, thus representing a novel Achilles heel for cancer cell survival and opening up novel applications of MCL-1 inhibitors like S63845 for the treatment of neuroblastoma. Here, BAK1 is linked to cancer.